Do not "double up" to compensate
Studies have shown that people taking GLP-1 receptor agonists for weight loss can experience a significant reduction in body weight, with some losing a significant percentage of their initial body weight over time
for 5 consecutive days resulted in a significant amelioration of animal weight loss, reduction of histopathological inflammation score, and myeloperoxidase levels compared with control mice
That may not necessarily be the case
Also, 30- to 40-year follow-up data from the International Childhood Cardiovascular Cohort Consortium have revealed consistent links between childhood obesity and early mortality from cardiovascular diseases, cancers, abnormal lipid metabolism and diabetes in adulthood [233,234,235,236] Nonetheless, the seven cohorts in this consortium reside in high-income countries (US, Australia and Finland), thus, critical data from middle- and lower-income countries are lacking [237]